PLS Reports Record Lithium Output as EV Demand Fuels Market Growth 
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges 
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions 
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal 
Meta Expands AI Training With Employee Activity Tracking Tools 
SK Hynix to Invest $13 Billion in AI Chip Packaging Facility 
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy 
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows 
European Car Sales Surge in March as EV and Hybrid Demand Accelerates 
$16B Michigan Data Center Project Boosts U.S. AI Infrastructure Expansion 
DeepSeek Launches V4 AI Models with Enhanced Reasoning and 1M Token Context Window 
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases 
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting 
Amazon Stock Rises as Meta Expands AWS Partnership for AI Infrastructure 
Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs 
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 
Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share 
Dublin, Feb. 25, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/zmzmmz/artificial_tears) has announced the addition of the "Artificial Tears - Global Strategic Analysis" report to their offering.
This report analyzes the worldwide markets for Artificial Tears in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 68 companies including many key and niche players such as:
- Abbott Medical Optics Inc. (US)
- Allergan, Inc. (US)
- Akorn, Inc. (US)
- Bausch & Lomb Incorporated. (US)
- Johnson & Johnson (US)
- Novartis International AG (Switzerland)
- Alcon, Inc. (Switzerland)
- Santen Pharmaceuticals Co, Ltd. (Japan)
- Novagali Pharma S.A. (France)
Key Topics Covered:
1. Industry Overview
2. Noteworthy Market Trends
3. Dry Eye Syndrome
4. Product Overview
5. Product Launches/Approvals/ Introductions
6. Recent Industry Activity
7. Focus On Select Global Players
8. Global Market Perspective
Total Companies Profiled: 68 (including Divisions/Subsidiaries 74)
- The United States (25)
- Canada (3)
- Japan (4)
- Europe (22)
- - France (3)
- - Germany (3)
- - The United Kingdom (5)
- - Italy (1)
- - Spain (1)
- - Rest of Europe (9)
- Asia-Pacific (Excluding Japan) (17)
- Africa (2)
- Middle-East (1)
For more information visit http://www.researchandmarkets.com/research/zmzmmz/artificial_tears
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Optical
